ReGen Sues FDA Over Menaflex Clearance Repeal
ReGen Biologics Inc. sued the U.S. Food and Drug Administration in Washington on Tuesday, alleging that the agency's rescission of marketing clearance for its Menaflex collagen meniscus implant was unlawful and...To view the full article, register now.
Already a subscriber? Click here to view full article